Vaccine efficacy is measured against symptomatic COVID‑19. It's quite possible that asymptomatic carriers transmit more (e.g., because they do not self isolate, or because they shed the virus for a longer period of time).
You may be right, I'm just saying that it does not follow from the results of vaccine clinical trials.